Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- Check3 days agoChange DetectedNew update dates were added to the study's update history: 2026-07-31, 2026-07-29, and 2026-07, and older dates were removed (2026-07-27, 2026-07-08, 2026-06). These changes reflect recent posting activity and maintenance of the page's update timeline.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire (Site 0209) and Gliwice, Silesian Voivodeship, Poland (44-102) to the locations, while removing the previous CIUSSS de l'Estrie-CHUS entry (Site 0209) and Gliwice 44-101. Renamed/standardized the Charing Cross Hospital site (Site 1603) to reflect the official institutional naming.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a new patch release. No user-facing content changes are described.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a recent deployment update to the site's software or content management system.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now features new user guidance sections and recruitment status language, and the Interventions header formatting has been adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', accompanied by a new revision tag (v3.6.0) indicating an updated page version.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded 'Revision: v3.5.5' and removed 'Revision: v3.5.4' text on the page. This indicates a new revision label for the document/versioning metadata.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.